Rhumbline Advisers Johnson & Johnson Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Johnson & Johnson stock. As of the latest transaction made, Rhumbline Advisers holds 4,369,317 shares of JNJ stock, worth $726 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

4,369,317

Previous 4,333,049 0.84%

Holding current value

$726 Million

Previous $685 Million 6.83%

% of portfolio

0.61%

Previous 0.67%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$144.38 - $157.78 $5.24 Million - $5.72 Million	36,268 Added 0.84%	4,369,317 $639 Million
Q1 2024 May 09, 2024	BUY	$155.22 - $162.74 $8.72 Million - $9.14 Million	56,157 Added 1.31%	4,333,049 $685 Million
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $2.63 Million - $2.87 Million	-18,066 Reduced 0.42%	4,276,892 $670 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $54.6 Million - $61.1 Million	-350,469 Reduced 7.54%	4,294,958 $669 Million
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $6.55 Million - $7.05 Million	42,415 Added 0.92%	4,645,427 $769 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $5.47 Million - $6.53 Million	36,210 Added 0.79%	4,603,012 $713 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $28.4 Million - $31.8 Million	177,102 Added 4.03%	4,566,802 $807 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $40 Million - $44.5 Million	247,673 Added 5.98%	4,389,700 $717 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $34.2 Million - $37.8 Million	203,201 Added 5.16%	4,142,027 $735 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $12.7 Million - $14.4 Million	80,426 Added 2.08%	3,938,826 $698 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $8.34 Million - $9.25 Million	53,475 Added 1.41%	3,858,400 $660 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $29.2 Million - $32.4 Million	-180,788 Reduced 4.54%	3,804,925 $614 Million
Q2 2021 Aug 05, 2021	SELL	$159.48 - $171.07 $32.1 Million - $34.4 Million	-201,330 Reduced 4.81%	3,985,713 $657 Million
Q1 2021 May 06, 2021	SELL	$153.07 - $170.48 $35.2 Million - $39.2 Million	-230,071 Reduced 5.21%	4,187,043 $688 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $2.1 Million - $2.41 Million	15,297 Added 0.35%	4,417,114 $695 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $405,978 - $444,876	-2,892 Reduced 0.07%	4,401,817 $655 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $17 Million - $20.5 Million	132,068 Added 3.09%	4,404,709 $619 Million
Q1 2020 May 06, 2020	BUY	$111.14 - $153.99 $1.44 Million - $2 Million	12,967 Added 0.3%	4,272,641 $560 Million
Q4 2019 Feb 05, 2020	SELL	$127.5 - $146.44 $1.48 Million - $1.7 Million	-11,637 Reduced 0.27%	4,259,674 $621 Million
Q3 2019 Oct 23, 2019	BUY	$126.95 - $142.14 $9.21 Million - $10.3 Million	72,582 Added 1.73%	4,271,311 $553 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $13.6 Million - $14.9 Million	-103,617 Reduced 2.41%	4,198,729 $585 Million
Q1 2019 May 01, 2019	SELL	$125.72 - $139.79 $10.5 Million - $11.6 Million	-83,333 Reduced 1.9%	4,302,346 $601 Million
Q4 2018 Jan 31, 2019	BUY	$122.84 - $147.84 $7.24 Million - $8.71 Million	58,932 Added 1.36%	4,385,679 $566 Million
Q3 2018 Nov 07, 2018	SELL	$121.58 - $142.88 $10.3 Million - $12 Million	-84,329 Reduced 1.91%	4,326,747 $598 Million
Q2 2018 Aug 06, 2018	SELL	$119.4 - $131.76 $3.74 Million - $4.13 Million	-31,341 Reduced 0.71%	4,411,076 $535 Million
Q1 2018 May 02, 2018	SELL	$125.1 - $148.14 $4.19 Million - $4.96 Million	-33,469 Reduced 0.75%	4,442,417 $569 Million
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $13.8 Million - $15.1 Million	105,104 Added 2.4%	4,475,886 $625 Million
Q3 2017 Nov 06, 2017	BUY	$129.47 - $135.38 $566 Million - $592 Million	4,370,782	4,370,782 $568 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Johnson & Johnson Transaction History